Immuron Reports Strong Sales Growth for Travelan® Across Global Markets

2 min read | January 17, 2025 11:30 AM AEDT | By Team Kalkine Media

Immuron Reports Strong Sales Growth for Travelan® Across Global Markets — Image source: shutterstock

Australia: Record Growth

Sales in Australia surged by 90% during the December 2024 Quarter, reaching AUD $1.851 million, compared to AUD $1.007 million in the September 2024 Quarter. Year-over-year, sales increased by a remarkable 315% compared to the December 2023 Quarter. For the December 2024 Half Year, Australian sales totaled AUD $2.858 million, reflecting a 54% increase from AUD $1.853 million during the corresponding period in 2023.

North America: Steady Expansion

In North America, Travelan® sales also demonstrated strong growth. Sales for the December 2024 Quarter rose 43% quarter-on-quarter to AUD $0.652 million, representing a 141% increase compared to the December 2023 Quarter. The Half Year figures showed a 57% year-over-year increase, with total sales of AUD $1.108 million. Breaking down the Half Year performance, the USA contributed AUD $0.731 million, while Canada added AUD $0.376 million.

Global Performance: A Milestone Year

Globally, Travelan® sales in the December 2024 Quarter amounted to AUD $2.5 million, a 70% increase from the previous quarter and 249% higher than the same period in 2023. For the December 2024 Half Year, sales totaled AUD $4.0 million, representing a 70% year-over-year increase.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.